THE WELCH COMPANY
440 Davis Court #1602
San Francisco, CA 94111-2496
415 781 5700
rodwelch@pacbell.net


S U M M A R Y


DIARY: March 15, 2008 05:54 AM Saturday; Rod Welch

Millie notfies UCSF initial response to Carboplatin treatment IBC subsides.

1...Summary/Objective
2...IBC Disease Response to Treatment after Starting Carboplatin Cetuximab
3...Cellulitis Possible Recurrence
4...Treatments Carboplatin Clarify Treatment Number Correlate to Cycles


..............
Click here to comment!

CONTACTS 

SUBJECTS
IBC Rash Inflammation Subsides Response  Teatment Cetuximab Carbopla

2403 -
2403 -    ..
2404 - Summary/Objective
2405 -
240501 - Follow up ref SDS 3 0000, ref SDS 1 0000.
240502 -
240503 -
240504 -
240505 -
240507 -  ..
2406 -
2407 -
2408 - Progress
2409 -
240901 - IBC Disease Response to Treatment after Starting Carboplatin Cetuximab
240902 -
240903 - Follow up ref SDS 3 KO7U, ref SDS 1 RU4U.
240904 -
240905 - Millie submitted ref DIT 1 0001 to Jackie notifying UCSF of various
240906 - issues, and saying...
240907 -
240908 -    1.  Please note that IBC sites seem less intense the day after
240909 -        treatment with cetuximab and carboplatin [first treatment was
240910 -        on 080313, ref SDS 2 TZ8I], This continues improvement reported
240911 -        a week ago, while still on cetuximab alone [on 080312,
240912 -        ref SDS 1 RU4U]. ref DIT 1 0001
240914 -  ..
240915 - This report follows the report yesterday on 080314 that the cancer
240916 - marker, CA 15-3 59, dropped 4 points, prior to starting new treatment
240917 - with cetuximab in combination with Carboplatin. ref SDS 3 KO7U
240918 -
240919 -
240920 -
2410 -

SUBJECTS
Cellulitis Recurrence Rash Inflammation Left Arm Change Diagnosis No

4203 -
420401 -  ..
420402 - Cellulitis Possible Recurrence
420403 -
420404 - Follow up ref SDS 4 V45J.
420405 -
420406 -    2.  Last night, Cellulitis may have relapsed slightly, so have
420407 -        resumed Keflex treatment. ref SDS 4 V45J, ref DIT 1 CD5O
420409 -  ..
420410 - Later in the day, after sending this letter at 0606 in the morning,
420411 - the inflammation and rash on the left arm fully subsided, so stopped
420412 - taking Keflex, and assume the problem was side effect from treatment
420413 - with cetuximab, as considered yesterday on 080314. ref SDS 4 YV9L
420414 -
420415 -            [On 080320 Kaiser and UCSF notified treatment for
420416 -            Cellulitis ended, because symptoms subsided after 1
420417 -            treatment. ref SDS 5 IJ5V
420419 -             ..
420420 -            [On 080409 Millie suffers Cellulitis recurrence,
420421 -            ref SDS 6 5Q6G; treated in Emergency Department with
420422 -            temperature of 101.9, ref SDS 6 0P96, later released for
420423 -            home care. ref SDS 6 M49N
420424 -
420425 -
420426 -
420427 -
420428 -
4205 -

SUBJECTS
Treatments Carboplatin Chemotherapy Clarify Treatment Number Correla

5003 -
500401 -  ..
500402 - Treatments Carboplatin Clarify Treatment Number Correlate to Cycles
500403 -
500404 - Follow up ref SDS 3 KO5P, ref SDS 2 0001.
500405 -
500406 -    3.  Please clarify the schedule of meetings to correlate with
500407 -        treatment cycles, as set out in the record beginning the new
500408 -        treatment protocol yesterday [Thursday, 080313]. ref SDS 2
500409 -        TZ8I, ref DIT 1 CD6L
500411 -  ..
500412 - Actually, this letter follows up the request yesterday asking UCSF to
500413 - submitted an updated schedule extending meetings for treatment over
500414 - the next several months. ref SDS 3 KO5P
500415 -
500416 -            [On 080320 Millie requested the schedule for meetings again
500417 -            to cover meetings for the next few months. ref SDS 5 QL8O
500418 -
500419 -
500420 -
500421 -
500422 -
500423 -
500424 -
5005 -